Overview

Effect of Food on Pharmacokinetics of Obeticholic Acid (OCA)

Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
This is an open label, randomized, balanced, single center, single dose, trial to assess the pharmacokinetic (PK) profile of OCA, glyco-OCA and tauro-OCA on an empty stomach (fasted condition) and following a high fat, high calorie meal (fed condition) in a 2-period, 2-sequence, crossover manner.
Phase:
Phase 1
Details
Lead Sponsor:
Intercept Pharmaceuticals
Treatments:
Chenodeoxycholic Acid